INTS6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.77709999733034E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.93141000000008E-05 |
Normal-vs-Stage2 |
2.914300E-02 |
Normal-vs-Stage3 |
1.37070021999364E-10 |
Normal-vs-Stage4 |
5.66769999821304E-08 |
Stage1-vs-Stage2 |
3.048200E-01 |
Stage1-vs-Stage3 |
4.401700E-03 |
Stage1-vs-Stage4 |
5.387600E-02 |
Stage2-vs-Stage3 |
1.323540E-02 |
Stage2-vs-Stage4 |
2.817700E-02 |
Stage3-vs-Stage4 |
7.240200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.23530000251915E-08 |
Normal-vs-AfricanAmerican |
3.31379999995995E-06 |
Normal-vs-Asian |
9.345400E-01 |
Caucasian-vs-AfricanAmerican |
5.309800E-01 |
Caucasian-vs-Asian |
3.014400E-01 |
AfricanAmerican-vs-Asian |
2.520200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.44949990583166E-10 |
Normal-vs-Female |
7.231700E-04 |
Male-vs-Female |
1.643170E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.22659999996144E-06 |
Normal-vs-Age(41-60Yrs) |
1.61599999999318E-05 |
Normal-vs-Age(61-80Yrs) |
1.8979000004915E-07 |
Normal-vs-Age(81-100Yrs) |
2.209200E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.145640E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.882790E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.113200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.382000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.442400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.640800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.421400E-01 |
Normal-vs-Grade 2 |
3.63389999999963E-05 |
Normal-vs-Grade 3 |
5.05980035647724E-10 |
Normal-vs-Grade 4 |
1.6128000046578E-08 |
Grade 1-vs-Grade 2 |
2.498400E-01 |
Grade 1-vs-Grade 3 |
1.275180E-01 |
Grade 1-vs-Grade 4 |
8.671600E-02 |
Grade 2-vs-Grade 3 |
1.097730E-02 |
Grade 2-vs-Grade 4 |
5.599200E-03 |
Grade 3-vs-Grade 4 |
2.882400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.658400E-03 |
Normal-vs-ccB subtype |
2.83519874244575E-11 |
ccA subtype-vs-ccB subtype |
4.03439999996369E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.48789999987464E-07 |
Normal-vs-N1 |
1.018870E-04 |
N0-vs-N1 |
2.248200E-01 |
|
|